Smoking cessation treatment in primary care
Turkish Journal of Clinical Research · 2025
DOI: 10.63909/1453008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Clinical Research, 2025. Verfasst von Cansu OZTURK KINA.
Abstract (Originalsprache)
obacco use remains a major global public health challenge, contributing to preventable morbidity and mortality. Smoking is directly linked to cancers, cardiovascular diseases, chronic obstructive pulmonary disease (COPD), and diabetes, while emerging evidence suggests e-cigarettes and HTPs may also harm respiratory and cardiovascular health. Smoking cessation significantly reduces these risks, offering immediate benefits (e.g., improved circulation within 20 minutes) and long-term advantages (e.g., reduced cancer risk). Effective cessation strategies include behavioral interventions like the 5As (Ask, Advise, Assess, Assist, Arrange) and 5Rs (Relevance, Risks, Rewards, Roadblocks, Repetition), alongside pharmacotherapy (e.g., varenicline, nicotine replacement therapy, bupropion). Combining counseling and medication enhances success rates. Special populations, such as cardiovascular disease patients and those with mental health disorders, require tailored approaches. National cessation programs, quitlines, and digital health tools further support quitting efforts. Healthcare providers play a critical role in promoting cessation through evidence-based, patient-centered interventions.
Zitieren
APA
KINA, C. O. (2025). Smoking cessation treatment in primary care. Turkish Journal of Clinical Research. https://doi.org/10.63909/1453008
Vancouver
KINA CO. Smoking cessation treatment in primary care. Turkish Journal of Clinical Research. 2025. doi:10.63909/1453008
BibTeX
@article{KINA2025,
author = {KINA, Cansu OZTURK},
title = {Smoking cessation treatment in primary care},
journal = {Turkish Journal of Clinical Research},
year = {2025},
doi = {10.63909/1453008}
}
EUVIMED